Showing all 11 results

  • Accrufer ferric maltol
    Out Of Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Accrufer (ferric maltol) Online For Sale

    DISEASE INDICATIONS: Iron deficiency

    MANUFACTURER: Shield Therapeutics

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Swissmedic (CH)

    Accrufer (ferric maltol) is an oral iron supplement used to treat iron deficiency anemia. Iron is an important mineral that the body needs to produce red blood cells.

    Read more
  • Adakveo crizanlizumab
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Adakveo (crizanlizumab) Online For Sale

    $1,808.10

    DISEASE INDICATIONS: Sickle Cell Disease

    MANUFACTURER: Novartis

    USAGE: Intravenous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Adakveo is a medication used to lower the frequency of vaso-occlusive crises in sickle cell disease patients by blocking a molecule called P-selectin.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Andexxa coagulation factor Xa recombinant inactivated zhzo
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) Online For Sale

    $23,583.00

    DISEASE INDICATIONS: Thromboembolism

    MANUFACTURER: Alexion Pharmaceuticals

    USAGE: Intravenous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Andexxa is a medication used to reverse anticoagulant effects caused by apixaban and rivaroxaban in patients suffering from uncontrolled, life-threatening bleeding.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Cablivi caplacizumab
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Cablivi (caplacizumab) Online For Sale

    $4,043.55

    DISEASE INDICATIONS: Acquired thrombotic thrombocytopenic purpura (aTTP)

    MANUFACTURER: Ablynx NV

    USAGE: Intravenous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Health Canada

    Therapeutic Goods Administration (TGA)

    Cablivi (caplacizumab) is a medication for treating acquired thrombotic thrombocytopenic purpura in adult patients by reducing the formation of blood clots in small blood vessels.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Evrenzo roxadustat
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Evrenzo (Roxadustat) Online For Sale

    From $168.00

    DISEASE INDICATIONS: Anemia

    MANUFACTURER: Astellas Pharma Inc. FibroGen

    USAGE: Intravenous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Pharmaceuticals and Medical Devices Agency (PMDA)

    Evrenzo (Roxadustat) is an oral medication prescribed for treating anemia in adults with chronic kidney disease (CKD). The medication stimulates the production of red blood cells by replicating the effects of low oxygen levels in the body.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Feraccru ferric maltol
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Feraccru (ferric maltol) Online For Sale

    $159.60

    DISEASE INDICATIONS: Iron deficiency

    MANUFACTURER: Shield Therapeutics

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Swissmedic (CH)

    Feraccru (ferric maltol) is an oral medication prescribed to treat iron deficiency anemia in adult patients with inflammatory bowel disease.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Givlaari givosiran
    Out Of Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Givlaari (givosiran) Online For Sale

    DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP)

    MANUFACTURER: Alnylam Pharmaceuticals

    USAGE: Subcutaneous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Pharmaceuticals and Medical Devices Agency (PMDA)

    Givlaari (givosiran) is a synthetic small interfering RNA medication given as a monthly subcutaneous injection to prevent attacks of acute intermittent porphyria by reducing the production of the liver enzyme ALAS1, which leads to toxic heme precursors accumulation.

    Read more
  • Inrebic fedratinib
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Inrebic (fedratinib) Online For Sale

    $5,137.65

    DISEASE INDICATIONS: Myelofibrosis

    MANUFACTURER: Impact Biomedicines, Inc.

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Inrebic (fedratinib) is an oral medication used to treat myelofibrosis by inhibiting the activity of the JAK2 protein. The medication helps to reduce the production of abnormal cells in the bone marrow and improve symptoms such as fatigue and enlarged spleen.

    Select options This product has multiple variants. The options may be chosen on the product page
  • In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Ondexxya (andexanet alfa) Online For Sale

    $16,093.35

    DISEASE INDICATIONS: Thromboembolism

    MANUFACTURER: Alexion Pharmaceuticals

    USAGE: Intravenous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Ondexxya (andexanet alfa) is a medication used to reverse the effects of blood thinners called Factor Xa inhibitors used to prevent and treat blood clots. The medication works by binding and neutralizing these anticoagulants.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Oxbryta voxelotor
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Oxbryta (voxelotor) Online For Sale

    $32,413.50

    DISEASE INDICATIONS: Sickle Cell Disease

    MANUFACTURER: Global Blood Therapeutics, Inc.

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Oxbryta (voxelotor) is a medication used to treat sickle cell disease (SCD) by increasing hemoglobin’s oxygen-binding ability, reducing sickling, and improving blood flow.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Ultomiris ravulizumab
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Ultomiris (ravulizumab) Online For Sale

    MANUFACTURER: Alexion Pharmaceuticals

    USAGE: Intravenous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Pharmaceuticals and Medical Devices Agency (PMDA)

    Ultomiris (ravulizumab) is a medication for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in adults. Its mechanism of action involves targeting complement protein C5 as it inhibits its activation, which may lead to hemolysis.

    Read more